Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
about
Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy.Treatment of COPD exacerbations. Pharmacologic options and modification of risk factors.Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDPseudomonal infections in patients with COPD: epidemiology and management.Economics of antibiotic use policies.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease.Newer fluoroquinolones in the treatment of acute exacerbations of COPDUse of azithromycin in the treatment of acute exacerbations of COPD.Integrated Theory of Health Behavior Change: background and intervention development.Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials.Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease
P2860
Q33182084-3DC7B50C-C8C4-4717-B59A-C73022CD81BDQ33739099-65041CA0-AE9D-40D8-964D-B9CDD48C70BFQ34197827-26594CAC-F0CA-4F2B-B4EA-EB9139D612B4Q34705590-6C94107B-BF26-4C20-99BF-A753CDF565F6Q35520406-5CA67549-5F6C-4404-92D7-5CDB91CF1ECCQ35535912-525057E0-B9ED-47E6-BF61-223B6E6B1115Q35627613-4F233ED4-0516-47BC-B43F-B0962ED4FA06Q35976867-E6F81286-9E8B-4CB6-8471-4FCF99774744Q36087058-5A812D4D-26E2-432A-AF34-8A3FB56610F1Q36765787-0ED44655-9358-4790-804E-D3DD3C6459F2Q37018822-6DC3EEA1-08F9-4FB7-83E5-F36C5E7BD216Q37115885-3A816D3A-E214-4750-88E1-5C00D44E05D8Q37422777-9E1704EE-A95C-45C6-8BB5-DF4F89061D88Q44205128-53F4DD50-2390-4436-83A2-B33BFC26F898Q57777851-B0B38CD7-044D-4524-963A-716FB8950217
P2860
Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical and economic consider ...... bations of chronic bronchitis.
@ast
Clinical and economic consider ...... bations of chronic bronchitis.
@en
type
label
Clinical and economic consider ...... bations of chronic bronchitis.
@ast
Clinical and economic consider ...... bations of chronic bronchitis.
@en
prefLabel
Clinical and economic consider ...... bations of chronic bronchitis.
@ast
Clinical and economic consider ...... bations of chronic bronchitis.
@en
P2093
P356
P1476
Clinical and economic consider ...... bations of chronic bronchitis.
@en
P2093
Angelillo VA
Campbell JC
Destache CJ
O'Donohue WJ
P304
P356
10.1093/JAC/43.SUPPL_1.107
P407
P478
43 Suppl A
P577
1999-03-01T00:00:00Z